J2h Biotech
Clinical trials sponsored by J2h Biotech, explained in plain language.
-
New NASH pill tested in humans for first time
Disease control CompletedThis early-stage trial tested a new oral drug called J2H-1702 in 100 healthy men to see if it is safe and how the body processes it. The drug is being developed for non-alcoholic steatohepatitis (NASH), a type of liver disease. The study was completed and used a placebo for compa…
Phase: PHASE1 • Sponsor: J2H Biotech • Aim: Disease control
Last updated Jun 23, 2026 12:08 UTC
-
New NASH drug shows promise in early trial
Disease control CompletedThis study tested a new drug called J2H-1702 in 87 adults with non-alcoholic steatohepatitis (NASH), a type of fatty liver disease. The goal was to see if the drug is safe and if it can reduce liver fat and scarring after 12 weeks compared to a placebo. Participants were randomly…
Phase: PHASE2 • Sponsor: J2H Biotech • Aim: Disease control
Last updated May 27, 2026 12:03 UTC
-
New drug for fatty liver disease takes first step in human testing
Knowledge-focused CompletedThis early-stage trial tested the safety and tolerability of a single dose of J2H-1702 in 16 healthy women. The drug is being developed for non-alcoholic steatohepatitis (NASH), a serious liver condition. Researchers measured how the body processes the drug and its effects, but t…
Phase: PHASE1 • Sponsor: J2H Biotech • Aim: Knowledge-focused
Last updated Jun 22, 2026 11:58 UTC